Precision Biosciences Inc
DTIL
Market Cap$60.66M
Close$
$16.72
224.6% upside
Current Fair Value
224.6% upsideUndervalued by 224.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $60.66 Million |
|---|---|
| Enterprise Value | $7.77 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $1.05 |
| Beta | 1.58 |
| Outstanding Shares | 7,999,288 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 6.42 |
|---|---|
| PEG | 6.21 |
| Price to Sales | 0.57 |
| Price to Book Ratio | 0.74 |
| Enterprise Value to Revenue | 0.1 |
| Enterprise Value to EBIT | -0.63 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 4.25 |
| Debt to Equity | 0.59 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Precision Biosciences Inc
CEO: Matthew Kane